M
WST icon

Mirova’s West Pharmaceutical WST Stock Holding History

Mirova’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-155
Closed -$34.7K – 140
2025
Q1 		$34.7K Hold
155
– – 0.01% 134
2024
Q4 		$50.8K Sell
155
-6
-4% -$1.89K 0.01% 128
2024
Q3 		$48.3K Hold
161
– – 0.01% 120
2024
Q2 		$53K Buy
+161
New +$56.9K 0.01% 123
2020
Q4 		– Sell
-243
Closed -$67K – 228
2020
Q3 		$67K Buy
+243
New +$64.3K 0.01% 116

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Mirova's WST Position: Q2 2025 in Review

Mirova sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 155 shares — an estimated $34.7K sold.

Mirova first reported a position in WST in Q3 2020 and held it in 5 quarters. The position peaked at $67K in Q3 2020. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Mirova reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Mirova sold 155 West Pharmaceutical shares in Q2 2025, an estimated $34.7K.
  • Mirova first reported a position in West Pharmaceutical in Q3 2020 and held it in 5 quarters.
  • Mirova's West Pharmaceutical position peaked at $67K in Q3 2020.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Mirova's 13F filing for Q2 2025, filed 13 Aug 2025.